What are the causes of upper gastrointestinal bleeding (UGIB) in a patient with encephalopathy, potentially due to liver disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Upper Gastrointestinal Bleeding in Patients with Encephalopathy

In patients with encephalopathy due to liver disease, upper gastrointestinal bleeding most commonly arises from esophageal varices (portal hypertension-related) and peptic ulcer disease, with variceal bleeding being the predominant concern in cirrhotic patients presenting with hepatic encephalopathy. 1, 2

Primary Variceal Causes in Cirrhotic Patients with Encephalopathy

  • Esophageal varices represent the leading cause of UGIB in cirrhotic patients with encephalopathy, occurring as a direct consequence of portal hypertension from underlying liver disease 2, 3
  • Gastric varices also contribute to bleeding in this population, though less commonly than esophageal varices 2
  • Variceal hemorrhage is both a precipitating factor for hepatic encephalopathy and a consequence of the same underlying cirrhosis that causes encephalopathy 4, 5

Nonvariceal Causes in Encephalopathic Patients

Common Nonvariceal Sources

  • Peptic ulcer disease (gastric and duodenal ulcers) remains highly prevalent, accounting for approximately 60% of nonvariceal UGIB cases combined, primarily related to Helicobacter pylori infection and NSAID use 1, 2
  • Gastric erosions and stress-related mucosal disease occur frequently in critically ill patients with cirrhosis, particularly those with coagulopathy, renal failure, or requiring mechanical ventilation 2
  • Mallory-Weiss tears result from forceful vomiting or retching, which may be precipitated by the underlying liver disease or its complications 1, 2

Additional Important Causes

  • Esophagitis and duodenitis represent inflammatory sources of bleeding 1, 2
  • Dieulafoy lesion, though accounting for only 1-2% of acute UGIB, is an underrecognized but serious cause consisting of a tortuous submucosal artery that penetrates the gastric mucosa, typically at the posterior gastric wall 1, 2
  • Angiodysplasia and vascular malformations 1, 2
  • Neoplasms, including gastric cancer and hepatocellular carcinoma eroding into the duodenum 2

Critical Bidirectional Relationship

The relationship between UGIB and hepatic encephalopathy is bidirectional and clinically crucial:

  • Gastrointestinal bleeding serves as a major precipitating factor for hepatic encephalopathy in cirrhotic patients, with 36% of ICU-admitted cirrhotic patients with encephalopathy having bleeding as a precipitant 4
  • Blood in the GI tract increases ammonia production by intestinal bacteria, worsening encephalopathy 6, 7
  • Conversely, hepatic encephalopathy itself is an independent predictor of mortality following the first episode of GI bleeding in cirrhotic patients 5
  • 82% of cirrhotic patients with encephalopathy have multiple concomitant precipitating factors, with infection (64%), acute kidney injury (63%), and bleeding (36%) being the most common 4

Rare but Catastrophic Causes

  • Aortoenteric fistula represents a rare but potentially catastrophic cause of GI hemorrhage 1, 2, 3
  • Hemosuccus pancreaticus accounts for approximately 1 in 500 cases of UGIB 1, 2
  • Hemobilia (bleeding into the biliary tree) 1, 2
  • Pancreatitis-related bleeding 1, 2

Clinical Context and Prognostic Implications

  • UGIB in cirrhotic patients carries mortality rates of 2-10%, with 7.4% mortality at 48 hours and 24% at 6 weeks following the first bleeding episode 1, 5
  • Renal failure, rebleeding, hepatocellular carcinoma, and hepatic encephalopathy are independent predictors of mortality in cirrhotic patients with UGIB 5
  • The presence of multiple concomitant precipitating factors (including bleeding) is associated with poor prognosis and increased risk of death or need for liver transplantation 4
  • Despite 75-85% of UGIB cases ceasing spontaneously, there remains high risk of rebleeding, massive hemorrhage, and death 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Upper GI Bleed Etiologies and Management in ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gastrointestinal Bleeding Causes and Incidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hepatic encephalopathy.

Nature reviews. Disease primers, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.